Table 3. Significantly enriched KEGG pathways in B. tabaci transcriptome.
| Pathway | Gene | P-value | Pathway ID | |
| Dif Expressed1 | Expressed2 | |||
| Starch and sucrose metabolism | 34 | 721 | 4.97E-14 | ko00500 |
| Antigen processing and presentation | 25 | 400 | 2.90E-13 | ko04612 |
| Metabolic pathways | 118 | 6788 | 2.08E-11 | ko01100 |
| Galactose metabolism | 21 | 447 | 4.32E-09 | ko00052 |
| Drug metabolism - cytochrome P450 | 21 | 553 | 1.63E-07 | ko00982 |
| Metabolism of xenobiotics by cytochrome P450 | 20 | 543 | 5.19E-07 | ko00980 |
| Lysosome | 25 | 893 | 3.05E-06 | ko04142 |
| Ascorbate and aldarate metabolism | 13 | 273 | 3.46E-06 | ko00053 |
| Viral myocarditis | 13 | 294 | 7.72E-06 | ko05416 |
| Methane metabolism | 6 | 59 | 2.45E-05 | ko00680 |
| Pentose and glucuronate interconversions | 13 | 330 | 2.61E-05 | ko00040 |
| Steroid hormone biosynthesis | 16 | 518 | 6.08E-05 | ko00140 |
| Retinol metabolism | 16 | 567 | 0.000171754 | ko00830 |
| Amyotrophic lateral sclerosis (ALS) | 9 | 203 | 0.000190324 | ko05014 |
| Porphyrin and chlorophyll metabolism | 11 | 336 | 0.000527308 | ko00860 |
| Parkinson's disease | 16 | 631 | 0.000555731 | ko05012 |
| Oxidative phosphorylation | 15 | 571 | 0.000573791 | ko00190 |
| Pyruvate metabolism | 11 | 354 | 0.000809227 | ko00620 |
| Citrate cycle (TCA cycle) | 9 | 256 | 0.001017943 | ko00020 |
| Phototransduction | 5 | 85 | 0.001512066 | ko04744 |
| Olfactory transduction | 6 | 127 | 0.001616717 | ko04740 |
| Fatty acid biosynthesis | 7 | 173 | 0.0016526 | ko00061 |
| Tight junction | 14 | 577 | 0.001826685 | ko04530 |
| Drug metabolism - other enzymes | 16 | 717 | 0.002077023 | ko00983 |
| Biosynthesis of unsaturated fatty acids | 6 | 142 | 0.002833766 | ko01040 |
| Cardiac muscle contraction | 8 | 257 | 0.004027393 | ko04260 |
| Spliceosome | 17 | 909 | 0.008783225 | ko03040 |
| Glutathione metabolism | 8 | 306 | 0.01103588 | ko00480 |
| Protein processing in endoplasmic reticulum | 16 | 897 | 0.01626663 | ko04141 |
| Hypertrophic cardiomyopathy (HCM) | 8 | 334 | 0.01779255 | ko05410 |
| Biosynthesis of secondary metabolites | 30 | 2047 | 0.01841002 | ko01110 |
| Allograft rejection | 1 | 3 | 0.02910126 | ko05330 |
| Graft-versus-host disease | 1 | 3 | 0.02910126 | ko05332 |
| PPAR signaling pathway | 7 | 304 | 0.0309862 | ko03320 |
| Complement and coagulation cascades | 4 | 124 | 0.03397758 | ko04610 |
| Arachidonic acid metabolism | 5 | 183 | 0.03465662 | ko00590 |
| Glyoxylate and dicarboxylate metabolism | 4 | 126 | 0.03571525 | ko00630 |
| Two-component system | 3 | 78 | 0.04136638 | ko02020 |
| Terpenoid backbone biosynthesis | 3 | 78 | 0.04136638 | ko00900 |
| Synthesis and degradation of ketone bodies | 3 | 80 | 0.0440508 | ko00072 |
1
The number of differentially expressed genes that belong to each KEGG pathway.
2
The number of expressed genes that belong to each KEGG pathway.